Abstract Dickkopf (Dkk)-3, an inhibitor of the Wnt/bcatenin pathway, is reported as a potential tumor suppressor gene in many cancers. To gain a better comprehension of the mechanisms involved in the carcinogenesis of oral squamous epithelium, protein expression and localization of Dkk-3 and b-catenin was investigated in normal epithelium, dysplasias and squamous cell carcinoma (SCC). An increase in b-catenin and Ki-67 expressions was observed from dysplasias to poorly differentiated SCC. Interestingly, an increase in Dkk-3 positive cells was also noted, which was correlated to the cancer progression step. A change in Dkk-3 localization during the transformation of normal oral epithelium to SCC was clearly observed. Dkk-3 was localized in the cell membrane in normal oral epithelium and in dysplasias, whereas that was localized in both cell membrane and cytoplasm in SCC. These results suggest that Dkk-3 is involved in the carcinogenesis of SCC with a distinct function from those in other cancers.
Introduction
Squamous cell carcinoma (SCC) is the most common malignant tumor in the oral cavity, and also one of the most common malignancies worldwide. Approximately, more than 266,000 new cases occur each year, which represents 5% all cancers in men and 2% in women (Johnson et al. 2005 ). Oral SCC is often accompanied by regional or distant metastasis posing difficulty in the management in about half of the patients.
So far, it is believed that oral SCC occurs due to the accumulation of genetic and epigenetic damages in several tumor suppressor genes (TSGs). However, little is known about the genes involved and its relation to the invasive capacity and metastatic ability (Ha et al. 2009; Schoop et al. 2009; Xia et al. 2011) . Our group has been working on a genome-wide analysis and reported members of the ING family (Borkosky et al. 2009; Cengiz et al. 2010; Gunduz et al. 2000 Gunduz et al. , 2002 Gunduz et al. , 2005 and Dickkopf (Dkk) family (Katase et al. 2008 (Katase et al. , 2010 as candidate TSGs in head and neck SCC.
Further analysis of a member of Dkk family, Dkk-3, seems to be significant in oral SCC. Dkk-3 encodes for the protein acting as antagonist of Wnt associated with cell proliferation and morphogenesis (Lee et al. 2009 ). Without Dkk-3, Wnt ligands bind to the receptor, frizzled and its coreceptor LRP5/6, which leads to intracellular accumulation and nuclear translocation of b-catenin, resulting in activation of c-myc and cyclinD1. This will then lead to overactivation of Wnt/b-catenin pathway and subsequent cell proliferation. Dkk-3 inhibits Wnt signaling by binding to the transmembrane receptors Krm and LRP5/6 and eventually induces proteosomal degradation of b-catenin.
Balanced function between Wnt and Dkk-3 contributes to controlled cell proliferation in normal tissue. The loss in the expression of Dkk-3 in various tumors suggest Dkk-3 as a candidate TSG, including glioma (Mizobuchi et al. 2008) , hepatocellular carcinoma , breast cancer (Veeck et al. 2009 ), prostate cancer (Zenzmaier et al. 2008) , gastrointestinal cancer (Maehata et al. 2008) , lung cancer (Licchesi et al. 2008 ) and renal cell cancer (Hirata et al. 2009 ). Epigenetic transcriptional silencing has been implicated in the decreased expression of Dkk-3 (Maehata et al. 2008) .
On the other hand, conserved Dkk-3 expression was reported in esophageal SCC. It has been reported that many esophageal SCC cell lines expressed Dkk-3 mRNA, and that Dkk-3 protein expression was conserved in 16.5% of esophageal SCC tissue samples (Maehata et al. 2008) . In another study, Dkk-3 protein expression was conserved in 65.7% of the cases in esophageal SCC, and was associated with clinicopathological data, suggesting that the upregulation of Dkk-3 may contribute to tumor invasion and metastasis in esophageal SCC .
Therefore, we hypothesized that Dkk-3 might have a distinct protein expression during carcinogenic transformation of squamous epithelium. To clarify this point, we investigated the expression and localization of Dkk-3 and its related proteins in normal oral squamous epithelium, dysplasias, carcinoma in situ (CIS) and oral SCC by immunohistochemistry.
Materials and methods

Tissues samples
A total of 65 tissue samples of oral SCC were obtained from 38 male and 27 female patients with a mean age of 67.3 ± 14.4 years ( Table 1) . Specimens studied were obtained from the Surgical Pathology Unit of Okayama University Hospital from 1997 to 2008. The ethical committee of Okayama University approved the study protocol. Tissue samples were fixed in 10% neutral buffered formalin and routinely processed for paraffin-embedded sections. Serial sections measuring 4 lm in thickness were prepared for hematoxylin and eosin (HE) and immunohistochemical analyses.
Specimens were histologically examined by at least two pathologists. The degree of dysplasia and the histological differentiation of SCC were classified according to the 2005 WHO classification. After thorough histological examination, portions of specimens in tissue samples were categorized as normal (N = 20), mild dysplasia (N = 19), moderate-severe dysplasia (N = 15), CIS (N = 5), well differentiated SCC (N = 42) and moderate-poorly differentiated SCC (N = 18).
Immunohistochemistry
Immunohistochemisty was performed using antibodies against human Dkk-3 (R & D Systems, Minneapolis, MN, USA), b-catenin (DAKO, Carpinteria CA, USA) and Ki-67 (DAKO, Carpinteria CA, USA) following the manufacturer's instructions. Briefly, antigen retrieval was done by heat treatment in a microwave immersed in 0.01 M citrate buffer (for Dkk-3 and Ki-67) or 0.01 M Tris buffer (pH9.0) with 0.001 M ethylenediamine tetra acetic acid (EDTA) (for b-catenin). Then, sections were reacted with primary antibodies against Dkk-3 (1:100), b-catenin (1:200) and Ki-67 (1:100) for 12 h at 4°C. For Dkk-3, this step was followed by reaction with biotinylated rabbit anti-goat serum (DAKO, 1:300) and VEC-TASTAIN Ò ABC Reagent (Vector Laboratories, Inc, Burlingame, CA, USA). For b-catenin and Ki-67, EnVision TM -mouse (DAKO, Carpinteria, CA, USA) was used. Immunoreaction was visualized with 0.5 mg/ml of diaminobenzidine and 0.03% hydrogen peroxide in trisbuffered saline (TBS).
After counterstaining with hematoxylin, sections were examined under a microscope with 9400 magnification. Five areas were randomly chosen in each sample and the number of positive cells in an area with 200 cells was counted. The results were expressed as the mean (in percentage) of 5 areas counted. Positive cells with membranous staining were classified as ''membrane positive cells'', whereas cells with cytoplasmic and membraneous staining were classified as ''cytoplasm positive cells''. Results
Localization of Dkk-3
Dkk-3 expression was detected in all specimens at variable intensities ( Fig. 1a-d ). Endothelial cells in capillaries and lymphatic vessels are also positive. In normal tissue, Dkk-3 was observed in the cell membrane of prickle cells and in the cytoplasm of parabasal cells, whereas basal cells were negative (Fig. 1e, arrowheads) . In mild dysplasia, Dkk-3 was observed in the cell membrane of prickle cells and in the cytoplasm of basal cells (Fig. 1b, f) . In moderate-severe dysplasia, Dkk-3 was widely detected in the cytoplasm from prickle to basal cell layer. In CIS and SCC, Dkk-3 was detected in both cell membrane and cytoplasm of the prickle cell like cells and basal cell like cells. In well differentiated SCC, Dkk-3 was observed in cytoplasm of prickle cell like cells and basal cell like cells in cancer nests (Fig. 1c, g ). In moderately-poorly differentiated SCC, Dkk-3 was observed in the cytoplasm of basal cell like cells with a more diffuse expression than those in well differentiated SCC (Fig. 1d ). Both in well differentiated SCC and moderately-poorly differentiated SCC, high number of Dkk-3 positive cells was observed in invasive fronts compared to other sites (Fig. 1c, d ).
Localization of b-catenin b-catenin expression was observed in the cell membrane from prickle cells to parabasal cells in normal epithelium.
b-catenin expression was also detected in the cytoplasm of basal cells (Fig. 2a, e) whereas Dkk-3 which was negative. In dysplasias, b-catenin was detected in the cell membrane of prickle cells and in the cytoplasm of basal cells (Fig. 2b,  f) . In well differentiated SCC, b-catenin was detected in the cell membrane of prickle cell like cells and in the cytoplasm of basal cell like cells. Similar to Dkk-3, invasive fronts of cancer nest were strongly positive with b-catenin (Fig. 2c) . b-catenin expression in moderate-poorly differentiated SCC was similar with Dkk-3 (Fig. 2d, h ). No nuclear localization was observed in any case.
Quantitative analyses
Total positive cell scoring Dkk-3 was observed in 58 out of 65 specimens (89.2%), and only 7 specimens (10.8%) were negative. The percentage of Dkk-3 positive cells in normal tissues was 22.5 ± 16.5%, which gradually increased among dysplasias and moderate-poorly differentiated SCC, and finally reached a plateau of 83.6-84.3% (Fig. 3a) . However, Dkk-3 positives cells decreased to 45.5 ± 29.2% in well differentiated SCC. Similar results were obtained for b-catenin expression (Fig. 3b) . A gradual increase in b-catenin positive cells was observed according to the degree of dysplasia, and reached a plateau of 86.0-87.8%. A decrease in b-catenin positive cell number and ratio were observed in well differentiated SCC (57.7 ± 22.7%). Membrane and cytoplasm positive cell scoring
To obtain a better understanding of Dkk-3 and b-catenin expression in the progression of the lesion, localization of the positive reaction was also determined. As shown in Fig. 3c , there was a gradual increase of membrane positive cells for Dkk-3 from normal tissue (17.7 ± 14.9%) to moderatesevere dysplasia (62.2 ± 11.6%). However, a marked decline in positive cells was obtained from CIS (11.2 ± 7.6%) to moderate-poorly differentiated SCC (1.4 ± 2.5%). An increase in cytoplasmic positive cells was also observed associated with the severity of dysplasia. Furthermore, a tremendous rise in membrane positive cells was observed during the transition from dysplasia to CIS. However, the number of cytoplasmic positive cells in well differentiated SCC (43.6 ± 27.9%) was not as high as that in CIS.
Results for b-catenin showed a similar pattern with Dkk-3 (Fig. 3d ). An increase in membrane positive cells was observed from normal tissue to moderate-severe dysplasia, followed by a remarkable decrease in carcinomas (CIS and SCCs). On the other hand, cytoplasmic positive cell percentages did not show variation among dysplasias compared to normal tissue, but a remarkable increase was observed in CIS and SCC.
Cell proliferation
Cell proliferation was assessed with Ki-67 index (Fig. 4) . As expected, Ki-67 index increased according to the cancer progression. The Ki-67 index in normal epithelium was 7.1 ± 3.5%. A rise in the Ki-67 index between mild dysplasia and moderate-severe dysplasia (16.8 ± 7.0% and 35.1 ± 11.0%, respectively) was detected compared to the normal epithelium. The Ki-67 index in CIS and well differentiated SCC were 54.6 ± 13.4% and 40.8 ± 9.8%, respectively. An increase in Ki-67 index was observed in highly proliferated areas and in invasion fronts. Moderatepoorly differentiated SCC showed the highest Ki-67 index (63.7 ± 17.2%), demonstrating similar cytoplasmic localization observed in Dkk-3 and b-catenin.
Discussion
Dkk-3 is a potential TSG in many cancers and an inhibitor of the Wnt/b-catenin pathway. However, it is was suggested that Dkk-3 could contribute to cancer invasion and metastasis in esophageal cancer (Maehata et al. 2008) . Therefore, we hypothesized that Dkk-3 has a distinct expression during the carcinogenesis of oral squamous epithelium. To get an insight in the role of Dkk-3 in oral SCC carcinogenesis, we investigated Dkk-3 and b-catenin expressions in normal oral squamous epithelium, dysplasias, CIS and SCC.
Immunohistochemical studies on Dkk-3 revealed a gradual increase in the number of positive cells in the carcinogenic process of the oral epithelium. Surprisingly, a gradual increase in b-catenin expression was also observed during the carcinogenic process. Immunolocalization was investigated to understand detailed changes in Dkk-3 and b-catenin expression during carcinogenesis. Dkk-3 membrane expression in prickle cells, b-catenin cytoplasmic expression at basal cell and membrane expression at prickle cells in normal epithelium coincided with the role of Dkk-3 as an inhibitor of the Wnt/b-catenin pathway. However, the mechanism behind Dkk-3 cytoplasmic expression in epithelial dysplasia is unclear. The presence of Dkk-3 in the cytoplasm seemed not to affect the localization of b-catenin, implying that Dkk-3 unlikely acts as an inhibitor of the Wnt/b-catenin pathway. The co-expression of Dkk-3 and b-catenin in cytoplasm suggests that Dkk-3 may have lost its inhibitory role in Wnt/bcatenin pathway.
Interestingly, well differentiated oral SCC showed a diminution of cytoplasmic Dkk-3 and b-catenin expression in proportion as the decrease in cell proliferation. This may be due to the presence of abundant keratin pearls which showed no reaction for any protein. Nevertheless, moderate-poorly differentiated SCCs have shown higher number of Dkk-3, b-catenin and Ki-67 positive cells than in those in CIS.
The detailed role of Dkk-3 in oral SCC and the phenomenon behind Dkk-3 cytoplasmic expression remain unclear. However, the results strongly suggest that Dkk-3 may have lost its inhibitory ability in Wnt/b-catenin pathway in the carcinoma stage. b-catenin expression was still observed albeit the increase in Dkk-3 expression. Further, the increase in the expression of Dkk-3 suggest that the gene encoding for Dkk-3 protein may not be acting as a TSG in oral SCC. A possible oncogenic property of Dkk-3 related to invasion and metastasis was implied in some studies. The presence of a larger number of Dkk-3 positive cells near the invasive front has been observed in esophageal SCC . Moreover, patients with loss of heterozygosity (LOH) at Dkk-3 locus have lower node metastasis and better prognosis than those without LOH (Katase et al. 2008) . Another is the antiapoptotic role of Dkk-3 wherein Dkk-3 display pro-survival properties by reducing caspase activity in mouse retina (Nakamura et al. 2007) . Similar function has also been pointed out in non-small cell lung cancer where the deletion of Dkk-3 by siRNA in H460 cells increased apoptosis and accumulation of reactive oxygen species (Jung et al. 2010 ).
In conclusion, this study showed that Dkk-3 displays a different behavior in oral SCC from other cancer. Dkk-3 expression localized in the cytoplasm increased during the carcinogenic transition of the oral epithelium. Our data suggests the loss of the inhibitory function of Dkk-3 in Wnt/b-catenin pathway. Further studies are needed to clarify the distinct function of Dkk-3 oral SCC carcinogenesis.
